Stock Analyst Initiations → This indicator is great for calling bottoms (From WealthPress) (Ad) Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsABLAbacus Life Initiated byB. RileySubscribe to MarketBeat All Access for the recommendation accuracy rating$11.41+13.5% $16.00BuyACIUAC Immune Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.65+17.1% $8.00BuyACLXArcellx Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$52.00-0.5% $70.00OverweightADCAgree Realty Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$60.74+0.8% $60.00NeutralALLOAllogene Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.50+1.6% $11.00OverweightAPLSApellis Pharmaceuticals Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$39.25-3.7% $46.00NeutralTech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.ASNDAscendis Pharma A/S Initiated byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating$135.10-1.7% $200.00BuyBHPBHP Group Initiated byCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$59.53+1.5%Buy ➝ BuyBZHBeazer Homes USA Initiated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.72+4.5% $37.00OutperformELEVElevation Oncology Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.02-1.2% $10.00OverweightEPRTEssential Properties Realty Trust Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$26.78+1.2% $30.00BuyFSSFederal Signal Initiated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$92.01+5.5%OutperformIMNMImmunome Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.94+1.6% $27.00OverweightLSEALandsea Homes Initiated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.92+2.2% $14.00OutperformNGDNew Gold Initiated byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.19-0.9%$3.00 ➝ $3.50Outperform ➝ OutperformNNNNNN REIT Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$41.77+2.0% $41.00NeutralOCULOcular Therapeutix Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.70-1.7% $15.00OverweightPYPLPayPal Initiated byNew Street ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$62.99+0.8% $80.00BuyQUADQuad/Graphics Initiated byRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.73+2.8% $7.50BuyRBRKRubrik Initiated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy rating$30.48+0.7% $50.00OverweightSLDBSolid Biosciences Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.26+8.1% $20.00OverweightSRPTSarepta Therapeutics Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$129.86+4.3% $157.00OverweightVSTSVestis Initiated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$12.32+1.7%Market PerformWPCW. P. Carey Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$56.39+0.6% $57.00NeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:24 AM ET. Stock Forecasts and Research Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
